The effect of progressive exercise training on untrained middle-aged men

The effect of progressive exercise training on redox status, myeloperoxidase concentration and hematological parameters in untrained middle-aged men

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200625047919N2

Enrollment

Registered

2020-08-09

Start date

2020-06-30

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immunity. Other disorders involving the immune mechanism, not elsewhere classified

Interventions

Intervention group (untrained): The subjects will perform a session of progressive exercise training on treadmill based on the modified Bruce test and at each stage that they are unable to continue, t

Eligibility

Sex/Gender

Male

Age

50 Years to 59 Years

Inclusion criteria

Inclusion criteria: Have age ranges 50-59 years No consumption of alcohol beverages No taking antioxidant supplements No suffering from chronic diseases No suffering from musculoskeletal injuries No smoking No participation in exercise training during last year

Exclusion criteria

Exclusion criteria: have cardiovascular and orthopedic disorders

Design outcomes

Primary

Measure	Time frame
Total Antioxidant Capacity. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Total Oxidative State. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Myeloperoxidase. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;White Blood Cells (WBC). Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Neutrophils. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Monocytes. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Lymphocytes. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Eosinophils. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Basophils. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Hematocrit (HCT). Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Hemoglobin (Hgb). Timepoint: Before, immediately	—

Measure

Time frame

Total Antioxidant Capacity. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Total Oxidative State. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Myeloperoxidase. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;White Blood Cells (WBC). Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Neutrophils. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Monocytes. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Lymphocytes. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Eosinophils. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Basophils. Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Hematocrit (HCT). Timepoint: Before, immediately after and one hour after the end of the intervention. Method of measurement: Measurement based on the protocol defined by the producer of the kit.;Hemoglobin (Hgb). Timepoint: Before, immediately

—

Secondary

Measure	Time frame
Blood pressure. Timepoint: Before, immediately and one hour after the end of the intervention. Method of measurement: Using the blood pressure device.;Triglyceride. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;Low-density lipoprotein. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;High-density lipoprotein. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;Cholesterol. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.	—

Measure

Time frame

Blood pressure. Timepoint: Before, immediately and one hour after the end of the intervention. Method of measurement: Using the blood pressure device.;Triglyceride. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;Low-density lipoprotein. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;High-density lipoprotein. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;Cholesterol. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Reza Rahimi Moghaddam

Islamic Azad University

sr_rahimi@yahoo.com+98 13 3342 2153

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026